tirzepatide kidney side effects Cancer: Evidence and Safety Data osa and tirzepatide Original sleep
Description
Discover how this type 2 diabetes medication affects digestion, why heartburn occurs, and evidence-based strategies to manage reflux symptoms whilst continuing treatment safely.
The SURMOUNT-5 trial (Aronne et al., NEJM 2025) showed that tirzepatide, a dual GIPGLP-1 receptor agonist, outperforms semaglutide in reducing weight and cardiometabolic risk in adults with obesity without diabetes
These include additional focus on social determinants of health, the healthcare system and physical activity behaviours including sleep
At Ethos Spa
New research has identified a potential, if small, added risk of smell and taste disturbances linked to GLP-1 use.
In a groundbreaking new study, Ozempic was found to be so effective at treating arthritis that people no longer needed treatment.
